INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 285 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.

Quarter-by-quarter ownership
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$348
+70.6%
11
+120.0%
0.00%
Q2 2023$204
+9.7%
50.0%0.00%
Q1 2023$186
+6.9%
50.0%0.00%
Q4 2022$17450.0%0.00%
Q3 2022$050.0%0.00%
Q2 2022$050.0%0.00%
Q1 2022$0
-100.0%
50.0%0.00%
Q4 2021$1,0000.0%50.0%0.00%
Q3 2021$1,0000.0%5
-37.5%
0.00%
Q2 2021$1,00080.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,615,321$23,697,00041.29%
ARK Investment Management 8,741,432$128,237,0003.23%
Nikko Asset Management Americas, Inc. 7,178,520$105,309,0001.66%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$1,635,0000.86%
Elmwood Wealth Management, Inc. 64,204$942,0000.82%
361 CAPITAL LLC 94,772$1,390,0000.38%
Artal Group S.A. 199,700$2,930,0000.11%
StoneX Group Inc. 14,982$220,0000.09%
Sumitomo Mitsui Trust Holdings, Inc. 7,178,520$105,309,0000.08%
PDT Partners, LLC 85,517$1,255,0000.08%
View complete list of INTELLIA THERAPEUTICS INC shareholders